ProBio's plasmid DNA manufacturing services help biotechnology and pharmaceutical companies overcome these hurdles through rapid turnaround, GMP-compliant production, high-yield proprietary platforms, and integrated support for AAV, lentiviral vector, mRNA, and nucleic acid therapeutic development. Whether you need plasmid DNA for IND-enabling studies, clinical trials, or commercial supply, ProBio delivers scalable solutions designed to accelerate advanced therapy development while maintaining quality, consistency, and regulatory readiness.